Variables | Low TB (n = 54) | High TB (n = 24) | p value |
---|---|---|---|
Age (y.o.) | 69 (40–87) | 69 (39–78 | 0.630 |
Gender (Male/Female) | 31 / 23 | 16 / 8 | 0.441 |
Neoadjuvant therapy | 25 (46.3%) | 11 (45.8%) | 0.970 |
PTPE | 12 (22.2%) | 6 (25.0%) | 0.788 |
Initial tumor marker | |||
CEA (ng/mL) | 3.6 (0.6–38.4) | 3.6 (0.7–28.0) | 0.862 |
CA19–9 (U/mL) | 76.6 (1.0–7898) | 106.6 (1.0–9278) | 0.681 |
Preoperative tumor marker | |||
CEA (ng/mL) | 3.0 (0.7–32.2) | 3.2 (0.5–32.3) | 0.492 |
CA19–9 (U/mL) | 56.9 (1.0–11,659) | 89.7 (1.0–9278) | 0.174 |
Type of liver resection | 0.109 | ||
No liver resection | 5 (9.3%) | 0 | |
S1,5,6,7,8 | 16 (29.6%) | 10 (41.7%) | |
S1,4,5,6,7,8 | 19 (35.2%) | 8 (33.3%) | |
S1,2,3,4 | 3 (5.6%) | 2 (8.3%) | |
S1,2,3,4,5,8 | 3 (5.6%) | 4 (16.7%) | |
Others | 8 (14.8%) | 0 | |
HPD | 3 (5.6%) | 1 (4.2%) | 0.797 |
Combined HA and/or PV resection | 23 (42.6%) | 16 (66.7%) | 0.050 |
Operation time (min) | 603 (383–1030) | 622 (422–972) | 0.482 |
Blood loss (ml) | 2165 (166–9907) | 2054 (587–6012) | 0.987 |
Histological type | |||
G1–2 / G3 | 51 / 3 (5.6%) | 18 / 6 (25%) | 0.013 |
TNM (UICC8th) | |||
pT: T0–3 / T4 | 42 / 12 (22.2%) | 12 / 12 (50.0%) | 0.014 |
pN: N0 / N1–2 | 33 / 21 (38.9%) | 7 / 17 (70.8%) | 0.009 |
M: M0 / M1a | 53 / 1 (1.9%) | 19 / 5 (20.8%) | 0.004 |
Residual tumor status | |||
R0 / R1 / R2 (M1/ margin positive) | 38 / 11 / 5 (1 / 4) | 15 / 3 / 6 (5 / 1) | 0.162 |
Postoperative hospital stay (days) | 45.5 (13–61) | 47.5 (17–325) | 0.931 |
Postoperative complication ≥ grade IIIb | 22 (40.7%) | 10 (41.7%) | 0.939 |
Postoperative chemotherapy | 37 (68.5%) | 19 (79.2%) | 0.335 |